South & Central America Gastric Cancer Diagnostic Procedure Market Forecast to 2028 –Regional Analysis – by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings [Instruments, Reagents & Consumables (Including Kits), and Services], Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer Types) and country.
The South & Central America gastric cancer diagnostic procedure market was valued at US$ 53.04 million in 2022 to US$ 78.73 million by 2028. It is estimated to grow at a CAGR of 6.8 % from 2022 to 2028.
Rising Awareness of Gastric Cancer to Fuel Asia Pacific Gastric Cancer Diagnostic Procedure Market During Forecast Period
No Stomach For Cancer (NSFC), a nonprofit organization, contributes to spreading awareness and educating people about stomach cancer. The organization supports research focused on screening, early detection, treatment, and prevention of stomach cancer. Hope For Stomach Cancer is another nonprofit organization that offers resources to patients, caregivers, and loved ones while promoting early detection and prevention in different communities (including medical and nonmedical). The organization develops and rolls out programs to assist stomach cancer patients to live the best possible life throughout the phases of the disease. Therefore, a rising number of gastric cancer awareness programs are expected to offer lucrative opportunities for the South & Central America gastric cancer diagnostic procedures market during the forecast period.
South & Central America Gastric Cancer Diagnostic Procedure Market Overview
The South & Central America gastric cancer diagnostic procedure market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America is expected to be the largest contributor to the gastric cancer diagnostic procedure market due to the rising prevalence of gastrointestinal diseases. Moreover, the increasing import of medical supplies required for gastric cancer diagnostics and the rising number of vendors providing these products indicate market growth in this region. Peru, Chile, Bolivia, and Ecuador are among the major contributors to the gastric cancer diagnostic procedure market in the Rest of South & Central America. The projected market growth in these countries is attributed to the prevalence of cancer and the rise in healthcare expenditure. Smoking and alcohol consumption are among the major risk factor associated with the high incidence of cancer in Chile. The country has a popular, reasonably well-functioning, well-organized, and effectively governed healthcare system. Chile, especially in the private sector, has good market potential for state-of-the-art medical technologies, which serves as a potential opportunity for the South & Central America gastric cancer diagnostic procedure market.
Exhibit: South & Central America Gastric Cancer Diagnostic Procedure Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Gastric Cancer Diagnostic Procedure Market Segmentation
The South & Central America gastric cancer diagnostic procedure market is segmented into healthcare providers, symptom types, body fluid, procedures, offerings, disease indication, and country.
Based on healthcare providers, the South & Central America gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The Hospitals segment held the largest South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on body fluid, the South & Central America gastric cancer diagnostic procedure market is segmented into Blood, urine, saliva, stomach wash/gastric juice, tissue and others. Blood segment held largest gastric cancer diagnostic procedure market share in 2022.
Based on offering, the South & Central America gastric cancer diagnostic procedure market is segmented into Instruments, Reagents & Consumables and Services. Reagents & Consumables segment held largest South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on Diagnostic procedure, the South & Central America gastric cancer diagnostic procedure market is categorized into endoscopic procedure, biopsy and tissue tests, lab test, in-vitro diagnostic tests, imaging test, molecular diagnostics, multiplexing molecular diagnostics, immunoassay, and others. The imaging segment held largest South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on disease condition, the South & Central America gastric cancer diagnostic procedure market is segmented into Early Gastric cancer and Gastric cancer advanced types. The Gastric cancer advanced type segment held larger South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on country, the South & Central America gastric cancer diagnostic procedure market has been categorized into Brazil, Argentina, and Rest of South & Central America. The Rest of South & Central America dominated the market in 2022.
Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; bioMerieux SA; Thermo Fisher Scientific Inc; Illumina Inc; and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the South & Central America gastric cancer diagnostic procedure market.
Rising Awareness of Gastric Cancer to Fuel Asia Pacific Gastric Cancer Diagnostic Procedure Market During Forecast Period
No Stomach For Cancer (NSFC), a nonprofit organization, contributes to spreading awareness and educating people about stomach cancer. The organization supports research focused on screening, early detection, treatment, and prevention of stomach cancer. Hope For Stomach Cancer is another nonprofit organization that offers resources to patients, caregivers, and loved ones while promoting early detection and prevention in different communities (including medical and nonmedical). The organization develops and rolls out programs to assist stomach cancer patients to live the best possible life throughout the phases of the disease. Therefore, a rising number of gastric cancer awareness programs are expected to offer lucrative opportunities for the South & Central America gastric cancer diagnostic procedures market during the forecast period.
South & Central America Gastric Cancer Diagnostic Procedure Market Overview
The South & Central America gastric cancer diagnostic procedure market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America is expected to be the largest contributor to the gastric cancer diagnostic procedure market due to the rising prevalence of gastrointestinal diseases. Moreover, the increasing import of medical supplies required for gastric cancer diagnostics and the rising number of vendors providing these products indicate market growth in this region. Peru, Chile, Bolivia, and Ecuador are among the major contributors to the gastric cancer diagnostic procedure market in the Rest of South & Central America. The projected market growth in these countries is attributed to the prevalence of cancer and the rise in healthcare expenditure. Smoking and alcohol consumption are among the major risk factor associated with the high incidence of cancer in Chile. The country has a popular, reasonably well-functioning, well-organized, and effectively governed healthcare system. Chile, especially in the private sector, has good market potential for state-of-the-art medical technologies, which serves as a potential opportunity for the South & Central America gastric cancer diagnostic procedure market.
Exhibit: South & Central America Gastric Cancer Diagnostic Procedure Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Gastric Cancer Diagnostic Procedure Market Segmentation
The South & Central America gastric cancer diagnostic procedure market is segmented into healthcare providers, symptom types, body fluid, procedures, offerings, disease indication, and country.
Based on healthcare providers, the South & Central America gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The Hospitals segment held the largest South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on body fluid, the South & Central America gastric cancer diagnostic procedure market is segmented into Blood, urine, saliva, stomach wash/gastric juice, tissue and others. Blood segment held largest gastric cancer diagnostic procedure market share in 2022.
Based on offering, the South & Central America gastric cancer diagnostic procedure market is segmented into Instruments, Reagents & Consumables and Services. Reagents & Consumables segment held largest South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on Diagnostic procedure, the South & Central America gastric cancer diagnostic procedure market is categorized into endoscopic procedure, biopsy and tissue tests, lab test, in-vitro diagnostic tests, imaging test, molecular diagnostics, multiplexing molecular diagnostics, immunoassay, and others. The imaging segment held largest South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on disease condition, the South & Central America gastric cancer diagnostic procedure market is segmented into Early Gastric cancer and Gastric cancer advanced types. The Gastric cancer advanced type segment held larger South & Central America gastric cancer diagnostic procedure market share in 2022.
Based on country, the South & Central America gastric cancer diagnostic procedure market has been categorized into Brazil, Argentina, and Rest of South & Central America. The Rest of South & Central America dominated the market in 2022.
Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; bioMerieux SA; Thermo Fisher Scientific Inc; Illumina Inc; and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the South & Central America gastric cancer diagnostic procedure market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Gastric cancer diagnostic procedure Market – by Healthcare Providers
1.3.2 South & Central America Gastric Cancer Diagnostic Procedure Market – By Symptom Types
1.3.3 South & Central America Gastric Cancer Diagnostic Procedure Market – By Body Fluid
1.3.4 South & Central America Gastric Cancer Diagnostic Procedure Market – By Procedures
1.3.5 South & Central America Gastric Cancer Diagnostic Procedure Market – By Offerings
1.3.6 South & Central America Gastric Cancer Diagnostic Procedure Market – By Disease Indication
1.3.7 South & Central America Gastric cancer diagnostic procedure Market – by Country
2. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surging Cases of Helicobacter Pylori Infection
5.2 Market Restraints
5.2.1 Shortage of Medical Laboratory Professionals
5.3 Market Opportunities
5.3.1 Rising Awareness of Gastric Cancer
5.4 Future Trends
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
5.5 Impact Analysis
6. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY HEALTHCARE PROVIDERS
7.1 Overview
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer Research Institutes
7.4.1 Overview
7.4.2 Cancer Research Institutes: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Oncology Specialty Clinics
7.5.1 Overview
7.5.2 Oncology Specialty Clinics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET ANALYSIS AND FORECASTS TO 2028 – BY SYMPTOM TYPES
8.1 Overview
8.2 Symptomatic
8.2.1 Overview
8.2.2 Symptomatic: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
8.3 Asymptomatic
8.3.1 Overview
8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY BODY FLUID
9.1 Overview
9.2 Blood
9.2.1 Overview
9.2.2 Blood: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.3 Urine
9.3.1 Overview
9.3.2 Urine: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Saliva
9.4.1 Overview
9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Stomach Wash/Gastric Juice
9.5.1 Overview
9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Tissue
9.6.1 Overview
9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY PROCEDURE
10.1 Overview
10.2 Endoscopic Procedure
10.2.1 Overview
10.2.2 Endoscopic Procedure: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.3 Biopsy and Tissue Tests
10.3.1 Overview
10.3.2 Biopsy and Tissue Tests: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.4 Lab Tests
10.4.1 Overview
10.4.2 Lab Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.5 In-Vitro Diagnostic Tests
10.5.1 Overview
10.5.2 In-Vitro Diagnostic Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Imaging Tests
10.6.1 Overview
10.6.2 Imaging Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Molecular Diagnostics
10.7.1 Overview
10.7.2 Molecular Diagnostics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Multiplexing Molecular Diagnostics and Immunoassay
10.8.1 Overview
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY OFFERINGS
11.1 Overview
11.2 Instruments
11.2.1 Overview
11.2.2 Instruments: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.3 Reagents and Consumables
11.3.1 Overview
11.3.2 Reagents and Consumables: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Services
11.4.1 Overview
11.4.2 Services: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE ANALYSIS – BY DISEASE INDICATION
12.1 Overview
12.2 Early Gastric Cancer
12.2.1 Overview
12.2.2 Early Gastric Cancer: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12.3 Gastric Cancer Advanced Types
12.3.1 Overview
12.3.2 Gastric Cancer Advanced Types: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
13. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
13.1 Overview
13.1.1 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country
13.1.1.1 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.1.3.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.1.3.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.1.3.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.1.3.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.1.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.1.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.1.6 Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.1.6.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.1.6.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.1.6.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.1.7 Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.1.8 Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.2 Argentina: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 Argentina: South & Central America Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.2.3.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.2.3.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.2.3.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.2.3.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.2.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.2.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.2.6 Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.2.6.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.2.6.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.2.6.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.2.7 Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.2.8 Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.3.3.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.3.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.3.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.3.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.3.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.3.6 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.3.6.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.3.6.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.3.6.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.3.7 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.3.8 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. COMPANY PROFILES
15.1 Bio-Rad Laboratories Inc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 bioMerieux SA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Thermo Fisher Scientific Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Illumina Inc
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Vela Diagnostics Holding Pte Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Gastric cancer diagnostic procedure Market – by Healthcare Providers
1.3.2 South & Central America Gastric Cancer Diagnostic Procedure Market – By Symptom Types
1.3.3 South & Central America Gastric Cancer Diagnostic Procedure Market – By Body Fluid
1.3.4 South & Central America Gastric Cancer Diagnostic Procedure Market – By Procedures
1.3.5 South & Central America Gastric Cancer Diagnostic Procedure Market – By Offerings
1.3.6 South & Central America Gastric Cancer Diagnostic Procedure Market – By Disease Indication
1.3.7 South & Central America Gastric cancer diagnostic procedure Market – by Country
2. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surging Cases of Helicobacter Pylori Infection
5.2 Market Restraints
5.2.1 Shortage of Medical Laboratory Professionals
5.3 Market Opportunities
5.3.1 Rising Awareness of Gastric Cancer
5.4 Future Trends
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
5.5 Impact Analysis
6. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY HEALTHCARE PROVIDERS
7.1 Overview
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer Research Institutes
7.4.1 Overview
7.4.2 Cancer Research Institutes: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Oncology Specialty Clinics
7.5.1 Overview
7.5.2 Oncology Specialty Clinics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET ANALYSIS AND FORECASTS TO 2028 – BY SYMPTOM TYPES
8.1 Overview
8.2 Symptomatic
8.2.1 Overview
8.2.2 Symptomatic: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
8.3 Asymptomatic
8.3.1 Overview
8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY BODY FLUID
9.1 Overview
9.2 Blood
9.2.1 Overview
9.2.2 Blood: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.3 Urine
9.3.1 Overview
9.3.2 Urine: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Saliva
9.4.1 Overview
9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Stomach Wash/Gastric Juice
9.5.1 Overview
9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Tissue
9.6.1 Overview
9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY PROCEDURE
10.1 Overview
10.2 Endoscopic Procedure
10.2.1 Overview
10.2.2 Endoscopic Procedure: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.3 Biopsy and Tissue Tests
10.3.1 Overview
10.3.2 Biopsy and Tissue Tests: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.4 Lab Tests
10.4.1 Overview
10.4.2 Lab Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.5 In-Vitro Diagnostic Tests
10.5.1 Overview
10.5.2 In-Vitro Diagnostic Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Imaging Tests
10.6.1 Overview
10.6.2 Imaging Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Molecular Diagnostics
10.7.1 Overview
10.7.2 Molecular Diagnostics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Multiplexing Molecular Diagnostics and Immunoassay
10.8.1 Overview
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY OFFERINGS
11.1 Overview
11.2 Instruments
11.2.1 Overview
11.2.2 Instruments: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.3 Reagents and Consumables
11.3.1 Overview
11.3.2 Reagents and Consumables: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Services
11.4.1 Overview
11.4.2 Services: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE ANALYSIS – BY DISEASE INDICATION
12.1 Overview
12.2 Early Gastric Cancer
12.2.1 Overview
12.2.2 Early Gastric Cancer: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12.3 Gastric Cancer Advanced Types
12.3.1 Overview
12.3.2 Gastric Cancer Advanced Types: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
13. SOUTH & CENTRAL AMERICA GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
13.1 Overview
13.1.1 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country
13.1.1.1 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.1.3.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.1.3.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.1.3.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.1.3.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.1.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.1.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.1.6 Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.1.6.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.1.6.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.1.6.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.1.7 Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.1.8 Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.2 Argentina: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 Argentina: South & Central America Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.2.3.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.2.3.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.2.3.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.2.3.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.2.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.2.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.2.6 Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.2.6.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.2.6.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.2.6.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.2.7 Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.2.8 Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.3.3.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.3.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.3.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.3.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.3.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.3.6 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.3.6.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.3.6.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.3.6.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.3.7 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.3.8 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. COMPANY PROFILES
15.1 Bio-Rad Laboratories Inc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 bioMerieux SA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Thermo Fisher Scientific Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Illumina Inc
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Vela Diagnostics Holding Pte Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 9. Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 10. Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 11. Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 12. Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 13. Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 14. Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 15. Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 18. Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 19. Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 20. Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 21. Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 22. Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 23. Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 24. Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 25. Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 26. Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 27. Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 28. Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 29. Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 30. Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 46. Organic Developments Done by Companies
Table 47. Inorganic Developments Done by Companies
Table 48. Glossary of Terms
Table 1. Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 9. Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 10. Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 11. Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 12. Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 13. Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 14. Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 15. Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 18. Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 19. Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 20. Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 21. Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 22. Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 23. Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 24. Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 25. Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 26. Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 27. Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 28. Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 29. Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 30. Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 46. Organic Developments Done by Companies
Table 47. Inorganic Developments Done by Companies
Table 48. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Gastric Cancer Diagnostic Procedure Market Segmentation
Figure 2. South & Central America Gastric Cancer Diagnostic Procedure Market, by Country
Figure 3. South & Central America Gastric Cancer Diagnostic Procedure Market Overview
Figure 4. South & Central America Gastric Cancer Diagnostic Procedure Market, By Symptom Types
Figure 5. South & Central America Gastric Cancer Diagnostic Procedure Market, By Country
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Gastric Cancer Diagnostic Procedure Market – Revenue Forecast and Analysis
Figure 10. South & Central America Gastric Cancer Diagnostic Procedure, by Healthcare Providers, 2021 & 2028 (%)
Figure 11. Diagnostic Laboratories: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Hospitals: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Cancer Research Institutes: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oncology Specialty Clinics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. South & Central America Gastric Cancer Diagnostic Procedure, by Symptom Type, 2021 & 2028 (%)
Figure 17. Symptomatic: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asymptomatic: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Gastric Cancer Diagnostic Procedure, by Body Fluid, 2021 & 2028 (%)
Figure 20. Blood: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Urine: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. South & Central America Gastric Cancer Diagnostic Procedure, by Procedures, 2021 & 2028 (%)
Figure 27. Endoscopic Procedure: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Biopsy and Tissue Tests: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Lab Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. In-Vitro Diagnostic Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Imaging Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Molecular Diagnostics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South & Central America Gastric Cancer Diagnostic Procedure, by Offerings, 2021 & 2028 (%)
Figure 36. Instruments: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Reagents and Consumables: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Services: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. South & Central America Gastric Cancer Diagnostic Procedure, by Disease Indication, 2021 & 2028 (%)
Figure 40. Early Gastric Cancer: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Gastric Cancer Advanced Types: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
Figure 44. Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Argentina: South & Central America Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of South & Central America: South & Central America Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
Figure 1. South & Central America Gastric Cancer Diagnostic Procedure Market Segmentation
Figure 2. South & Central America Gastric Cancer Diagnostic Procedure Market, by Country
Figure 3. South & Central America Gastric Cancer Diagnostic Procedure Market Overview
Figure 4. South & Central America Gastric Cancer Diagnostic Procedure Market, By Symptom Types
Figure 5. South & Central America Gastric Cancer Diagnostic Procedure Market, By Country
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Gastric Cancer Diagnostic Procedure Market – Revenue Forecast and Analysis
Figure 10. South & Central America Gastric Cancer Diagnostic Procedure, by Healthcare Providers, 2021 & 2028 (%)
Figure 11. Diagnostic Laboratories: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Hospitals: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Cancer Research Institutes: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oncology Specialty Clinics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. South & Central America Gastric Cancer Diagnostic Procedure, by Symptom Type, 2021 & 2028 (%)
Figure 17. Symptomatic: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asymptomatic: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Gastric Cancer Diagnostic Procedure, by Body Fluid, 2021 & 2028 (%)
Figure 20. Blood: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Urine: South & Central America Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. South & Central America Gastric Cancer Diagnostic Procedure, by Procedures, 2021 & 2028 (%)
Figure 27. Endoscopic Procedure: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Biopsy and Tissue Tests: South & Central America Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Lab Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. In-Vitro Diagnostic Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Imaging Tests: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Molecular Diagnostics: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Others: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South & Central America Gastric Cancer Diagnostic Procedure, by Offerings, 2021 & 2028 (%)
Figure 36. Instruments: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Reagents and Consumables: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Services: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. South & Central America Gastric Cancer Diagnostic Procedure, by Disease Indication, 2021 & 2028 (%)
Figure 40. Early Gastric Cancer: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Gastric Cancer Advanced Types: South & Central America Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
Figure 44. Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Argentina: South & Central America Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of South & Central America: South & Central America Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
